Obsidian Therapeutics Appoints Julie Feder as Chief Financial Officer [Yahoo! Finance]
Aura Biosciences, Inc. (AURA)
Company Research
Source: Yahoo! Finance
and gene therapies, today announced the appointment of Julie Feder as Chief Financial Officer. Ms. Feder is an accomplished executive, bringing over 20 years of strategic finance experience in life sciences and healthcare. "I am thrilled to welcome Julie to our leadership team," said Madan Jagasia, M.D., Chief Executive Officer of Obsidian. "Her breadth of experience across finance, strategy and operations at private and public companies will be critical as Obsidian continues clinical development of our lead engineered tumor-infiltrating (TIL) cell therapy, OBX-115, as the program is progressing rapidly towards a registration-enabling path." "I am delighted to join Obsidian at such a pivotal time for the company," said Ms. Feder. "The team has developed an exciting lead program in OBX-115 with the potential to deliver best-in-class efficacy and safety, transforming outcomes in patients with metastatic melanoma and non-small cell lung cancer. I look forward to continuing to build o
Show less
Read more
Impact Snapshot
Event Time:
AURA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AURA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AURA alerts
High impacting Aura Biosciences, Inc. news events
Weekly update
A roundup of the hottest topics
AURA
News
- Aura Biosciences (NASDAQ:AURA) is now covered by analysts at Evercore ISI. They set an "outperform" rating on the stock.MarketBeat
- Aura Biosciences to Participate in the 8th Annual Evercore Healthcare ConferenceGlobeNewswire
- Aura Biosciences: Bringing Not-Quite-Viruses Closer To Fruition In Cancer [Seeking Alpha]Seeking Alpha
- Aura Biosciences GAAP EPS of -$0.40 beats by $0.07 [Seeking Alpha]Seeking Alpha
- Aura Biosciences Reports Third Quarter 2025 Financial Results and Business HighlightsGlobeNewswire
AURA
Earnings
- 11/13/25 - Beat
AURA
Sec Filings
- 11/17/25 - Form 144
- 11/17/25 - Form 4
- 11/13/25 - Form 10-Q
- AURA's page on the SEC website